Walela, founded by James Balman in 2021 and headquartered in Chicago, Illinois, is a medical device company dedicated to improving fetal and maternal health outcomes. The company's core mission is to innovate sensor technology that accurately measures fetal heart rate and blood pH, thereby reducing unnecessary medical interventions such as Cesarean sections. Walela aims to ensure safer deliveries for all mothers and newborns through its specialized medical technology.
Notable affiliated individuals include founder James Balman, whose vision drives the company's innovative approach. Walela has garnered attention from investors focused on advancing healthcare technology. Key achievements include the development and successful implementation of their sensor technology, which has shown promise in clinical settings. Walela's impact lies in its potential to revolutionize prenatal care, offering more precise monitoring and contributing to better health outcomes for both mothers and babies.
